Keyphrases
Absolute Difference
12%
Brain Metastases
37%
Confidence Interval
12%
Expected number
12%
Fixed Effects Model
12%
Hazard Ratio
50%
Individual Patient Data Meta-analysis
100%
Inter-trial
12%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Memory Impairment
12%
Meta-analysis
12%
Metastasis-free Survival
25%
Number of Events
12%
Number of Patients
12%
Observation-driven
12%
Overall Survival
37%
Overall Survival Benefit
12%
Progression-free Survival
25%
Prophylactic Cranial Irradiation
100%
Randomized Trial
12%
Small Sample Size
12%
Stage III Non-small Cell Lung Cancer
12%
Survival Disparities
12%
Medicine and Dentistry
Arm
12%
Brain Metastasis
37%
Hazard Ratio
50%
Memory Disorder
12%
Meta-Analysis
100%
Metastasis Free Survival
25%
Non Small Cell Lung Cancer
100%
Overall Survival
50%
Patient-Data
100%
Progression Free Survival
25%
Prophylactic Cranial Irradiation
100%
Randomized Controlled Trial
37%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Metastasis
75%
Memory Disorder
25%
Metastasis Free Survival
50%
Non Small Cell Lung Cancer
100%
Overall Survival
100%
Progression Free Survival
50%
Randomized Controlled Trial
75%
Biochemistry, Genetics and Molecular Biology
Metastasis Free Survival
50%
Overall Survival
100%
Patient Coding
100%
Progression Free Survival
50%
Randomized Controlled Trial
75%
Sample Size
25%
Immunology and Microbiology
Arm
25%
Metastasis Free Survival
50%
Overall Survival
100%
Patient Coding
100%
Progression Free Survival
50%
Sample Size
25%
Neuroscience
Memory Disorder
50%
Meta-Analysis
100%